Literature DB >> 27604332

Prevalence, goals of care and long-term outcomes of patients with life-limiting illness referred to a tertiary ICU.

Neil R Orford1, Sharyn L Milnes2, Nigel Lambert2, Laura Berkeley2, Stephen E Lane3, Nicholas Simpson2, Tania Elderkin2, Allison Bone2, Peter Martin4, Charlie Corke2, Rinaldo Bellomo5, Michael Bailey5.   

Abstract

OBJECTIVE: To describe the prevalence, characteristics, long-term outcomes and goals-of-care discussions of patients with objective indicators of life-limiting illnesses (LLIs) referred to the intensive care unit. DESIGN, SETTING AND PATIENTS: A prospective, observational, cohort study of all adult inpatients referred to the ICU by the medical emergency team or by direct referral, during the period 30 August 2012 to 1 February 2013, at a tertiary teaching hospital in Australia. MAIN OUTCOME MEASURES: Mortality, LLIs, discharge destination and documentation on goals of care in medical record.
RESULTS: A total of 649 of 1024 patients referred to the ICU had an LLI, and only 34.4% of these patients had goals of care documented. Overall, 49.2% were admitted to the ICU, 48.4% were discharged home, and the 1-year mortality was 35.1%. The most common LLI criteria were heart disease (52.2%), chronic obstructive pulmonary disease (24.8%) and frailty (23.7%). The highest 1-year mortality was associated with pre-hospital residence in a nursing home (64.9%), dementia (63.3%), cancer (60.8%) and frailty (50.6%). Analysis of patients by clinical trajectory showed that 1-year mortality was significantly higher for patients with cancer (59.6%), combined organ failure and frailty (47.3%), frailty (43.8%) and organ failure (23.6%), compared with patients with no LLI (P < 0.0001).
CONCLUSIONS: A high proportion of patients referred to the ICU have an LLI, and this is associated with prolonged hospital length of stay and a high 1-year mortality, and only one-quarter have documented discussions on goals of care. Patients with cancer-related and frailty-related LLIs have the worst survival trajectories.

Entities:  

Mesh:

Year:  2016        PMID: 27604332

Source DB:  PubMed          Journal:  Crit Care Resusc        ISSN: 1441-2772            Impact factor:   2.159


  6 in total

1.  Measuring Outcomes of Clinical Care: Victorian Emergency Laparotomy Audit Using Quality Investigator.

Authors:  Claire L Stevens; Christopher Brown; David A K Watters
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

2.  [65/m-Multiple organ failure from sepsis due to four quadrant peritonitis : Preparation course anesthesiological intensive care medicine: case 21].

Authors:  Andrej Michalsen; Jochen Dutzmann
Journal:  Anaesthesiologie       Date:  2022-06-23

3.  Mixed-methods evaluation of three natural language processing modeling approaches for measuring documented goals-of-care discussions in the electronic health record.

Authors:  Alison M Uyeda; J Randall Curtis; Ruth A Engelberg; Lyndia C Brumback; Yue Guo; James Sibley; William B Lober; Trevor Cohen; Janaki Torrence; Joanna Heywood; Sudiptho R Paul; Erin K Kross; Robert Y Lee
Journal:  J Pain Symptom Manage       Date:  2022-02-16       Impact factor: 5.576

4.  A Qualitative Exploration of Seriously Ill Patients' Experiences of Goals of Care Discussions in Australian Hospital Settings.

Authors:  Moira O'Connor; Kaaren J Watts; Warren D Kilburn; Kitty Vivekananda; Claire E Johnson; Sharon Keesing; Georgia K B Halkett; Josephine Shaw; Valerie Colgan; Kevin Yuen; Renate Jolly; Simon C Towler; Anupam Chauhan; Margherita Nicoletti; Anton D Leonard
Journal:  J Gen Intern Med       Date:  2020-10-09       Impact factor: 5.128

5.  Don't forget shared decision-making in the COVID-19 crisis.

Authors:  Nicholas Simpson; Sharyn Milnes; Daniel Steinfort
Journal:  Intern Med J       Date:  2020-06       Impact factor: 2.048

6.  Are older and seriously ill inpatients planning ahead for future medical care?

Authors:  Amy Waller; Rob Sanson-Fisher; Balakrishnan R Kichu Nair; Tiffany Evans
Journal:  BMC Geriatr       Date:  2019-08-05       Impact factor: 3.921

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.